 |
Amphastar Pharmaceuticals
AMPH
|
17.3 |
$ 21.65 |
- |
$ 1.01 B |
USA |
 |
MorphoSys AG
MOR
|
-0.591 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Advaxis
ADXS
|
-82.4 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Akouos
AKUS
|
-1.13 |
- |
0.23 % |
$ 488 M |
USA |
 |
Allakos
ALLK
|
-1.56 |
- |
- |
$ 28.6 M |
USA |
 |
AlloVir
ALVR
|
-3.61 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
I-Mab
IMAB
|
595 |
- |
- |
$ 866 M |
China |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 |
- |
- |
$ 1.01 B |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Midatech Pharma plc
MTP
|
0.796 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 |
- |
- |
$ 40.3 B |
USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 |
- |
- |
$ 10.1 M |
USA |
 |
Applied Therapeutics
APLT
|
-0.476 |
- |
- |
$ 8.42 M |
USA |
 |
Aptorum Group Limited
APM
|
29.4 |
$ 0.9 |
-0.18 % |
$ 6.62 M |
China |
 |
Biophytis SA
BPTS
|
-17.6 |
- |
-13.47 % |
$ 169 M |
France |
 |
Genfit SA
GNFT
|
4.22 K |
- |
2.54 % |
$ 160 B |
France |
 |
ACADIA Pharmaceuticals
ACAD
|
-21.1 |
$ 22.3 |
- |
$ 3.7 B |
USA |
 |
Aptinyx
APTX
|
-1.56 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 |
- |
- |
$ 7.46 M |
Israel |
 |
Brainstorm Cell Therapeutics
BCLI
|
-5.59 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
8 |
- |
-4.8 % |
$ 255 M |
USA |
 |
AIkido Pharma
AIKI
|
-45.5 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Cara Therapeutics
CARA
|
-6.7 |
- |
-3.03 % |
$ 260 M |
USA |
 |
CASI Pharmaceuticals
CASI
|
-26.1 |
- |
- |
$ 35.4 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 |
- |
- |
- |
Russia |
 |
Fennec Pharmaceuticals
FENC
|
0.832 |
$ 6.85 |
- |
$ 196 M |
USA |
 |
ChromaDex Corporation
CDXC
|
-5.05 |
- |
-0.88 % |
$ 598 M |
USA |
 |
Aeterna Zentaris
AEZS
|
4.4 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Galectin Therapeutics
GALT
|
-1.92 |
$ 2.37 |
- |
$ 151 M |
USA |
 |
AgeX Therapeutics
AGE
|
-1.85 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aravive
ARAV
|
-0.158 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Greenwich LifeSciences
GLSI
|
-47.7 |
$ 23.99 |
- |
$ 312 M |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
-0.807 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
BioNTech SE
BNTX
|
4.1 |
$ 102.06 |
- |
$ 27.2 B |
Germany |
 |
Checkpoint Therapeutics
CKPT
|
-0.833 |
- |
- |
$ 169 M |
USA |
 |
Avenue Therapeutics
ATXI
|
0.871 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 |
- |
- |
$ 26.5 M |
USA |
 |
Heron Therapeutics
HRTX
|
-4.31 |
$ 1.19 |
- |
$ 198 M |
USA |
 |
Aquestive Therapeutics
AQST
|
-7.26 |
$ 4.1 |
- |
$ 438 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
-4.86 |
$ 23.42 |
- |
$ 2.98 B |
USA |
 |
ImmuCell Corporation
ICCC
|
23.1 |
$ 8.25 |
- |
$ 74.5 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 |
$ 1.42 |
- |
$ 378 M |
Britain |
 |
Aptose Biosciences
APTO
|
388 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
AstraZeneca PLC
AZN
|
76.5 |
- |
- |
$ 96.9 B |
Britain |
 |
AVROBIO
AVRO
|
0.957 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Inventiva S.A.
IVA
|
-9.77 |
$ 5.13 |
- |
$ 138 M |
France |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 |
$ 2.92 |
- |
$ 4.81 M |
Israel |
 |
BeiGene, Ltd.
BGNE
|
-208 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Kamada Ltd.
KMDA
|
-386 |
$ 8.2 |
- |
$ 260 M |
Israel |